Pfizer Q3 Results
- BSE: 500680
- NSE: PFIZER
- ISIN: INE182A01018
- Sector: Major Drugs
BSE
4,709.35
-109.50 (-2.27%)
-109.50 (-2.27%)Volume755.00
Updated: Wed 11 Mar, 2026 | 15:28:03
NSE
4,700-103.50 (-2.15%)
-103.50 (-2.15%)Volume17.19 K
Updated: Wed 11 Mar, 2026 | 15:30:03
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
- Total Income₹645.03 Cr.(19.90%)
- Operating Profit₹155.73 Cr.(18.71%)
- Profit After Tax₹141.84 Cr.(11.16%)
- Operating Margin24.14%(-0.99%)
Note: Comparison is on YoY basis
Quarterly - Pfizer Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 25 | Sep 24 | QoQ Comp | Dec 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 489.30 | 414.33 | 14.67% | 397.02 | 20.28% |
| Depreciation/ Amortization | 14.26 | 14.99 | -0.14% | 17.55 | -3.65% |
| Operating Income | 155.73 | 174.26 | -27.79% | 142.95 | 18.71% |
| Net Income | 141.84 | 158.35 | -24.96% | 129.98 | 11.16% |
| Other Operating Expenses Total | 91.77 | 87.86 | 2.21% | 115.49 | -7.44% |
| Net Income Before Taxes | 191.95 | 215.23 | -24.83% | 175.94 | 11.31% |
| Total Revenue | 645.03 | 588.59 | 0.42% | 539.97 | 19.90% |
| Selling/ General/ Admin Expenses Total | 100.30 | 100.76 | 5.95% | 89.37 | 4.16% |
| Diluted Normalized EPS | 40.41 | 34.61 | -2.20% | 27.14 | 44.90% |